论文部分内容阅读
目前,脊髓灰质炎(脊灰)病毒灭活疫苗(Inactivated Poliovirus Vaccine)在我国获准上市,为科学规范使用IPV,根据卫生部指示,中国疾病预防控制中心组织卫生部免疫规划专家咨询委员会,依照《疫苗流通和预防接种管理条例》等有关规定,参考世界卫生组织(WHO)等国外技术文件和疫苗使用说明书,制定了IPV使用指导意见,并于2009年9月7日以中疾控发[2009]403号文件下发。
At present, the Inactivated Poliovirus Vaccine has been approved for listing in China. In order to scientifically regulate the use of IPV, according to instructions from the Ministry of Health, China Center for Disease Control and Prevention organized an immunization planning expert advisory committee of the Ministry of Health in accordance with the “ Vaccine circulation and vaccination regulations ”and other relevant regulations, with reference to the World Health Organization (WHO) and other foreign technical documents and vaccine instructions, developed IPV use guidance, and in September 7, 2009 to disease control [2009 ] No. 403 document issued.